Status:
COMPLETED
Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
Lead Sponsor:
Beech Tree Labs, Inc.
Collaborating Sponsors:
Norwich Clinical Research Associates Ltd.
Hill Top Research
Conditions:
Oral Herpes Simplex
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if a new drug treatment is effective to block the development of a cold sore lesion following Ultra Violet (UV) exposure.
Detailed Description
This was a multi-center, randomized, evaluator and subject-blind, placebo controlled study design The objective of this study was to evaluate the ability of the test articles to block the development...
Eligibility Criteria
Inclusion
- Clinical history of recurrent cold sores averaging 2 or more episodes per year
- UV exposure is known to cause a cold sore outbreak
Exclusion
- History of abnormal reactions to sunlight
- Used antiviral therapy directly prior to entering study
- Any other condition which in the opinion of the Investigator may affect the results or place the subject at undue risk.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
303 Patients enrolled
Trial Details
Trial ID
NCT01902303
Start Date
July 1 2013
End Date
February 1 2015
Last Update
April 28 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hill Top Research
St. Petersburg, Florida, United States, 33714
2
Hill Top Research
Cincinnati, Ohio, United States, 45242
3
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States, 29464